| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/08/2013 | CN103083278A Roxithromycin capsule and preparation method thereof |
| 05/08/2013 | CN103083277A Antifungal capsule for dogs and cats |
| 05/08/2013 | CN103083264A Doxycycline tablet and preparation method thereof |
| 05/08/2013 | CN103083263A Trovafloxacin ear drop pill for dogs and cats |
| 05/08/2013 | CN103083262A Itraconazole tablet for pets and preparation method thereof |
| 05/08/2013 | CN103083249A Method for preparing berberine chitosan drug-carrying microsphere by salting-out process |
| 05/08/2013 | CN103083246A Doxycycline soluble powder and preparation method thereof |
| 05/08/2013 | CN103083245A Thiamphenicol soluble powder and preparation method thereof |
| 05/08/2013 | CN103083242A Preparation method of carboxymethyl chitosan nanoparticle |
| 05/08/2013 | CN103083235A Myricetin nanosuspension and preparation method thereof |
| 05/08/2013 | CN103083227A Ribavirin slow release nasal gel used for treating cold and preparation method of gel |
| 05/08/2013 | CN103083224A Method for preparing dexamethasone slow-release medicine carrier |
| 05/08/2013 | CN103083208A Oral compositions containing botanical extracts |
| 05/08/2013 | CN103083196A Synergistically active ternary anti-microbial mixtures |
| 05/08/2013 | CN103081940A Compound chlorhexidine acetate microemulsion disinfectant and its preparation method |
| 05/08/2013 | CN102697742B Preparation process of cefozopran hydrochloride for injection |
| 05/08/2013 | CN102614136B Potassium sodium dehydroandrographolide succinate composition for injection, and freeze-dried powder injection and preparation method for freeze-dried powder injection |
| 05/08/2013 | CN102552907B Application of non-surrounding displaced phthalocyanine zinc in preparing sonosensitizer |
| 05/08/2013 | CN102552679B Medicine for treating vital myocarditis |
| 05/08/2013 | CN102526625B Medicament for treating hepatitis B and preparation method for medicament |
| 05/08/2013 | CN102526072B Application of Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy-sterane triterpene in preparation of medicament for preventing and/or treating EV71 infection |
| 05/08/2013 | CN102525963B Netilmicin sulfate lyophiled powder injection and preparation method thereof |
| 05/08/2013 | CN102525883B Voriconazole suppository and preparation method and application thereof |
| 05/08/2013 | CN102499949B Ointment for treating chapped hands and feet |
| 05/08/2013 | CN102475677B Preparation method of lincomycin hydrochloride injection |
| 05/08/2013 | CN102430065B Medicament for treating epidemic parotitis |
| 05/08/2013 | CN102429946B Chinese medicinal composition for preparing anti-influenza virus medicament |
| 05/08/2013 | CN102406869B Intestine-protecting and detoxifying micro pellets and use thereof |
| 05/08/2013 | CN102397540B Recombinant phage vaccine for avian influenza A and construction method for recombinant phage vaccine |
| 05/08/2013 | CN102327603B Preparation method and use method of loach aeromonas sobria vaccine |
| 05/08/2013 | CN102293975B Medicine for treating phthisis and preparation method thereof |
| 05/08/2013 | CN102283905B Chinese herbal medicinal compound preparation for preventing and treating fish saprolegniasis and application thereof |
| 05/08/2013 | CN102233136B Recombinant plasmid vaccine for treating hepatitis B and composition thereof |
| 05/08/2013 | CN102233005B Medicinal vinegar for treating fungal beriberi and preparation method thereof |
| 05/08/2013 | CN102225069B Drug composition causing low drug resistance, and its preparation method and application |
| 05/08/2013 | CN102212131B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/08/2013 | CN102210858B Combined EV71 (enterovirus 71)-HA (hepatitis A) vaccine |
| 05/08/2013 | CN102206607B Three genes deleted mutant of enterohemorrhagic escherichia coli O157:H7 |
| 05/08/2013 | CN102198243B Oviduct dredging medicament for removing blood stasis and warming meridians |
| 05/08/2013 | CN102198135B Use of new stable Prulifloxacin hydrochloride in preparation of anti-infection medicines |
| 05/08/2013 | CN102139100B Application of protein Mip in immune protection of coxiella burnetii |
| 05/08/2013 | CN102139041B Pharmaceutical composition for preventing and treating red body diseases of shrimps |
| 05/08/2013 | CN102105473B Tricyclic nitrogen containing compounds and their use as antibacterials |
| 05/08/2013 | CN101903026B Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 05/08/2013 | CN101843640B Natural anti- virus and composition comprising thereof |
| 05/08/2013 | CN101829104B Application of ring A coupling flavonolignan in preparing medicaments for treating viral hepatitis B |
| 05/08/2013 | CN101829095B Use of lignanoid containing benzyloxy flavones in preparation of drugs for treating viral hepatitis B |
| 05/08/2013 | CN101829088B Application of B/E bi-methoxy silybin in preparing medicaments for treating viral hepatitis B |
| 05/08/2013 | CN101801907B Compounds isolated from antrodia cinnamomea and use thereof |
| 05/08/2013 | CN101785749B Sterilizing skin moistening liquid soap |
| 05/08/2013 | CN101703769B Novel tetravalent inactivated vaccine for streptococcus suis disease |
| 05/08/2013 | CN101693885B Anti-HBV (hepatitis B Virus) nicotine medicine composition |
| 05/08/2013 | CN101588818B Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 05/08/2013 | CN101450954B Nucleotide analogs and use thereof, and medicament composition containing nucleotide analogs |
| 05/08/2013 | CN101385776B Anti influenza use of main chemical component and active component in scabriculous herbamoslae |
| 05/08/2013 | CN101282984B Immunogens for meningitidis-a vaccines |
| 05/08/2013 | CN101218224B Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/08/2013 | CN101203509B Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8435960 Devices for improved wound management |
| 05/07/2013 | US8435958 Method for producing pectin hydrolysis products |
| 05/07/2013 | US8435939 Polypeptide anti-HIV agent containing the same |
| 05/07/2013 | US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 05/07/2013 | CA2598460C Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 05/07/2013 | CA2530363C Carrier proteins for vaccines |
| 05/07/2013 | CA2491131C Novel compounds as histone deacetylase inhibitors |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/07/2013 | CA2360347C Improved expression of hiv polypeptides and production of virus-like particles |
| 05/02/2013 | WO2013063462A2 Method of treating hcv infection with a small molecule chk2 inhibitor |
| 05/02/2013 | WO2013063405A1 Methods of treating gram-negative microbial infections |
| 05/02/2013 | WO2013063248A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
| 05/02/2013 | WO2013063012A1 Myxovirus therapeutics, compounds, and uses related thereto |
| 05/02/2013 | WO2013062959A2 Continuous subcutaneous administration of interferon-alpha to hepatitis b infected patients |
| 05/02/2013 | WO2013062445A1 Pharmaceutical composition and kit for treating bacterial infections |
| 05/02/2013 | WO2013062028A1 Hiv replication inhibitor |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013061919A1 Novel compound and method for producing same |
| 05/02/2013 | WO2013061816A1 Novel compound contained in manuka honey and use of same |
| 05/02/2013 | WO2013061295A1 Inhibition of viral gene expression |
| 05/02/2013 | WO2013061101A1 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens |
| 05/02/2013 | WO2013060889A1 Compounds for the treatment of influenza |
| 05/02/2013 | WO2013060864A1 Chimeric molecule involving oligomerized fasl extracellular domain |
| 05/02/2013 | WO2013060744A2 Compounds having an ethr inhibiting activity - use of said compounds as drugs - pharmaceutical composition and product containing said compounds |
| 05/02/2013 | WO2013059984A1 Derivative of methacryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug |
| 05/02/2013 | WO2013059928A1 Hiv protease inhibitors |
| 05/02/2013 | WO2013059896A1 Use of pyranonaphthoquinone as an anti-viral agent; pharmaceutical composition containing pyranonaphthoquinones; medicament containing pyranonaphthoquinones for treating infections by dengue virus |
| 05/02/2013 | WO2013052006A8 Parp-1 inhibitors |
| 05/02/2013 | WO2013036846A3 N4 derivatives of deoxycytidine prodrugs |
| 05/02/2013 | WO2013036622A3 Antiviral peptides effective against hepatitis c virus |
| 05/02/2013 | WO2013023166A3 Hapivirins and diprovirins |
| 05/02/2013 | WO2013016468A3 Compositions and methods for improving potency and breadth or hiv antibodies |
| 05/02/2013 | WO2012177892A3 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis |
| 05/02/2013 | WO2012173392A9 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection |
| 05/02/2013 | US20130109647 Methods and compositions for treating hepatitis c virus |
| 05/02/2013 | US20130109623 G-csf and water-soluble polymer conjugate |
| 05/02/2013 | US20130109618 Rna virus-derived peptides with modified side chains |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | US20130108675 Organic compounds |
| 05/02/2013 | US20130108649 Modulation of ul24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection |
| 05/02/2013 | US20130108615 Date Pit Composition For The Treatment Of Animals |